Cell Point India Ltd vs Vijaypd Ceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Cell Point (India) Ltd is ₹ 14.95 as of 23 Oct 15:30 . The P/E Ratio of Cell Point (India) Ltd is 0 as of March 2026 .The P/E Ratio of Vijaypd Ceutical Ltd is 25.5 as of March 2026 . The Market Cap of Cell Point (India) Ltd is ₹ 0 crore as of March 2026 .The Market Cap of Vijaypd Ceutical Ltd is ₹ 127.33 crore as of March 2026 . The Dividend Payout of Cell Point (India) Ltd changed from 27.65 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Vijaypd Ceutical Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Cell Point (India) Ltd

Cell Point (India) Limited was formerly incorporated as 'Cell Point (India) Private Limited' on April 10, 2013 as a Private Company with Registrar of Companies, Andhra Pradesh.
The Company was subsequently converted into a public Company vide fresh Certificate of Incorporation dated November 25, 2022.
The Promoters started business as small mobile retailers in Vizag, Vishakhapatnam, Andhra Pradesh in 2001 and took over the running businesses of sole Proprietary Concerns of the Promoters, M/s.
Cell Point and M/s.
Mobile King as a going concern basis with all of their respective assets and liabilities. The Company currently sells all its products directly through 75 stores spread across Andhra Pradesh, of which 2 stores are owned properties and 73 stores are on leased properties.

About Vijaypd Ceutical Ltd

VijayPD Ceutical Limited is engaged in the business of distributor and supplier of the pharmaceutical products and consumer goods sectors, offering a comprehensive range of services.
It provide a wide range of products, serving both the pharmaceutical and wellness industries, as well as the fast moving consumer goods (FMCG) market, including pharmaceutical and wellness products such as medicines, including injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral products; vitamins, hormones, enzymes, and wellness tonics; serums and diagnostic test kits, and fast-moving consumer goods, such as personal care and toiletries like soaps, sanitizers, and baby care items; ayurvedic product; cosmetics and food products and additionally, provide dental products, crude drugs.

FAQs for the comparison of Cell Point (India) Ltd and Vijaypd Ceutical Ltd

Which company has a larger market capitalization, Cell Point (India) Ltd or Vijaypd Ceutical Ltd?

Market cap of Cell Point (India) Ltd is 27 Cr while Market cap of Vijaypd Ceutical Ltd is 161 Cr

What are the key factors driving the stock performance of Cell Point (India) Ltd and Vijaypd Ceutical Ltd?

The stock performance of Cell Point (India) Ltd and Vijaypd Ceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cell Point (India) Ltd and Vijaypd Ceutical Ltd?

As of October 26, 2026, the Cell Point (India) Ltd stock price is INR ₹14.95. On the other hand, Vijaypd Ceutical Ltd stock price is INR ₹82.9.

How do dividend payouts of Cell Point (India) Ltd and Vijaypd Ceutical Ltd compare?

To compare the dividend payouts of Cell Point (India) Ltd and Vijaypd Ceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.